Pluristem Therapeutics Inc (PSTI)

[zzaatt]

Summary of wisdom from "AutoEich999":

-- Sitting there suckling the near empty PSTI teat
-- doing squat except approving bonuses and raises for their co goons
-- Nyum nyum nyum.

Eich reviews the above offering from 999 of AutoEich999:

That made me laugh....thanks....and yeah....unbelievable.

further opinion by our resident expert 999 (he's debating Dr.Lantis, renowned vascular surgeon!!! Don't worry, we know 999 is up to the task, LOL !!!!!!! ):

The big KOL was a dud. says 999

Don’t care if they sold it for $10 billion. These guys have done such a disservice for their shareholders, they will always be scum in my eyes.

Reversing advanced gangrene (as presented by Dr.Lantis) and selling Pluristem for $10 billion?!!!!!, (that's over a hundred bagger!!! ) and Scott999 calls them scum !!!!! YES, 999 calls the people who are achieving this: SCUM !!!!!!!

There you have it!! 999 speaks and "Eich" is laughing (I think we can join him in that!!)

-------------------------------------------------------------------------
Dr. John Lantis is the Vice Chairman of the Department of Surgery at Mount Sinai West in New York City, where he is also the Chief of Vascular and Endovascular Surgery, and the Director of Surgical Clinical Research. He holds the academic title of Professor of Surgery at the Icahn School of Medicine at Mount Sinai. Dr. Lantis’ clinical practice spans the fields of Vascular/Endovascular Surgery, and lower extremity wound healing. He directs a clinical/basic science research program in the field of lower extremity wound healing and tissue repair and is published extensively. He is a founding member of the American
Board of Wound Medicine and Surgery. He currently sits on the editorial board of WOUNDS, and is a reviewer for half a dozen other journals. To date he is/or has been the principal investigator on more than 55 multi center and single center chronic wound and vascular surgery trials.